Mr. Ibrahem/Rasburicase
Clinical data
Trade namesElitek, Fasturtec
AHFS/Drugs.comMonograph
License data
Pregnancy
category
  • AU: B2
Routes of
administration
Intravenous infusion
Legal status
Legal status
  • AU: S4 (Prescription only)
  • US: ℞-only
  • EU: Rx-only
  • In general: ℞ (Prescription only)
Pharmacokinetic data
BioavailabilityN/A
Elimination half-life18 hrs
Identifiers
  • Aspergillus urate oxidase
Chemical and physical data
FormulaC1521H2381N417O461S7
Molar mass34109.66 g·mol−1
 ☒NcheckY (what is this?)  (verify)

Rasburicase, sold under the brand names Elitek among others, is a medication used for high uric acid levels that occur as a result of tumor lysis syndrome.[1] It is given by gradual injection into a vein.[1]

Common side effects include nausea, fever, swelling, anxiety, headache, diarrhea, and low phosphate.[1] Other side effects may include anaphylaxis and methemoglobinemia.[3] It should not be used in people with G6PD deficiency.[3] It is the urate oxidase enzyme created by recombinant DNA technology.[3]

Rasburicase was approved for medical use in Europe in 2001 and the United States in 2002.[1][4] It is on the World Health Organization's List of Essential Medicines.[5] In the United Kingdom it costs the NHS about £350 per 7.5mg vial as of 2021.[2] This amount in the United States costs about 5,000 USD.[6]

References

edit
  1. ^ a b c d e f "DailyMed - ELITEK- rasburicase kit". dailymed.nlm.nih.gov. Archived from the original on 20 March 2021. Retrieved 16 October 2021.
  2. ^ a b BNF (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 994. ISBN 978-0-85711-369-6.{{cite book}}: CS1 maint: date format (link)
  3. ^ a b c "Rasburicase Monograph for Professionals". Drugs.com. Archived from the original on 5 August 2019. Retrieved 16 October 2021.
  4. ^ "Fasturtec". Archived from the original on 28 December 2020. Retrieved 16 October 2021.
  5. ^ World Health Organization (2023). The selection and use of essential medicines 2023: web annex A: World Health Organization model list of essential medicines: 23rd list (2023). Geneva: World Health Organization. hdl:10665/371090. WHO/MHP/HPS/EML/2023.02.
  6. ^ "Elitek Prices, Coupons & Patient Assistance Programs". Drugs.com. Archived from the original on 20 January 2021. Retrieved 16 October 2021.